Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
September 15, 2023 | Company news, Leadership, fishawack health
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
WASHINGTON, D.C., Sept. 12, 2023 — Fishawack Health (FH) announces it is expanding its executive leadership team with the addition of Amar Urhekar as its new Chief Operating Officer (COO), a pioneer in bringing together interdisciplinary teams to solve client challenges and accelerate growth.
Urhekar will play a key role on the company’s Executive Committee as he unites 1,600 employees as one team under a single vision, breaking down barriers to faster-connect patients to life-enhancing therapies. All business units — Consulting; Medical; Policy; Value, Evidence and Access; Marketing; and Digital Experience and Technology — will report to Urhekar. With a holistic view of the business, he will continue building global cross-functional teams, spanning North America, Europe and Asia, uniting the collective intelligence, deep expertise and creativity of FH’s experts to develop agile and innovative solutions along the path to product commercialization.
Urhekar is an experienced, global leader who has spent more than 20 years transforming agencies to lead the markets they serve in the Asia Pacific Region, Europe and the U.S. As COO, he will oversee all of FH’s services, execute the company’s business strategy, support and recruit skilled team members, and nurture the ongoing digital advancements for the company. He will also serve as a member of Fishawack Health’s board of directors.
“The challenges that face our industry are not siloed and neither should our creativity, strategies and mission to drive exceptional outcomes,” said Fishawack Health CEO Jon Koch. “It takes the right experience to see the connections and pinpoint solutions that drive lasting advancements in health. Amar’s experience is uncommon, spanning continents and helping brands thrive at different stages of a product lifecycle. He complements our leadership in a way that will ensure we reach our full potential for clients and staff alike.”
Prior to joining FH, Urhekar served as Global Group President at Evoke, leading a multi-regional creative, marketing and advertising agency platform. In 2019, Urhekar took charge of Ashfield Health as its Global President where he drove substantial growth and galvanized internal teams and leaders under a single vision, simplifying the internal structure to ensure the smoother delivery of client work. Under his direction, the network grew substantially and won its first Mid-size Network of the Year recognition.
Prior to his work at Ashfield, Urhekar was a founding member of McCann Health India and then took on leadership roles in China, Japan and Singapore, including as Regional Director, APAC. He then relocated to the U.S., as President of McCann Health Americas where he doubled the size of the network.
“FH is at an exciting time in its evolution,” said Urhekar. “The last few years have pushed the pace of change in our industry characterized by the growth of complex therapies, accelerated approvals, legislative changes and competitive pressures. The industry is at an inflection point and a specific assimilation of expertise is needed. FH’s response to these challenges is different than other organizations. The commercialization partner has unrivaled expertise in healthcare policy, a strong command of value, evidence and access, and an arsenal of novel digital and data-driven experiences. We’re at the scale to be truly agile and we have the expertise and services to drive integration in a unique way that benefits clients and, ultimately, patients. This is what attracted me to FH.”
Urhekar will report to Koch. Currently, both Koch and Urhekar are focused on completing the next stage of FH’s integration strategy. Already, there is excitement for what they and the executive leadership team will accomplish together with a significant announcement planned in the coming month.
About Fishawack Health
Established in 2001, Fishawack Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our 1,600 experts combine their knowledge and expertise across our core disciplines — Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience and Technology — to create the connections that make better health happen. We partner with clients to navigate the complex and rapidly changing healthcare ecosystem. Together, we realize the potential of strategies and solutions, to bring innovation to the hands of those who can benefit from it. Visit us at and follow us on Twitter and LinkedIn.
Contact information:
Global contact:
Natasha Cowan
natasha.cowan@fishawack.com
US contact:
Marita Gomez
marita.gomez@fishawack.com
This content was provided by Avalere Health
Company Details
Latest Content from Avalere Health
The desire for connected customer experiences unites stakeholders
Milo Elmir, Managing Consultant, examines the trends changing the behaviors of 3 healthcare stakeholders—patients, payers, and healthcare professionals—and explores how building human-centered solutions will help biopharmaceutical and medical technology companies...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the...
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology
Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders
In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.
How we’re empowering our teams to fight healthcare inequality
Welcoming Sheena Amin-Liebman as our new Diversity and Inclusion Director. Sheena will play a vital role in creating an inspiring environment that empowers staff to better guide its clients in...
Accelerating HTA and payer submissions: how digital connectivity is driving faster patient access
Sotiria Papanicolaou, Chief Consulting Officer at PRMA Consulting, a member of Fishawack Health, explains how the combination of digital innovation and expert insight are removing roadblocks and speeding up the...
Future focus: 3 tools for launching fast in the face of uncertainty
Dan Twibell, Head of Commercial Strategy, Consulting at Fishawack Health, reveals 3 fundamental tools for lean biotechs approaching a rapid launch. He gives his advice on how to manage resources...
Fishawack Health appoints new CEO, Jonathan Koch
Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.
Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
Elizabeth Landon brings exceptional leadership from a career supporting and scaling people-based businesses in the professional services and non-profit sectors.